Here is a complete guide to drug dosage forms, drawn from Lippincott Illustrated Reviews: Pharmacology, Katzung's Basic and Clinical Pharmacology, and Goodman & Gilman's:
Drug Dosage Forms
A dosage form is the physical formulation in which a drug is presented for administration. The choice of dosage form determines the route of administration, onset of action, bioavailability, and patient compliance.
Overview of Routes of Administration
"The route of administration is determined by properties of the drug (e.g., water or lipid solubility, ionization) and by the therapeutic objectives (e.g., need for rapid onset, long-term treatment, or restriction to a local site)." - Lippincott
1. ENTERAL (via the GI tract)
A. Oral (PO) - Most Common Route
The most common, convenient, and economical method of drug administration.
| Sub-type | Description | Examples |
|---|
| Immediate-release (IR) | Plain uncoated tablet; rapid dissolution | Paracetamol, aspirin |
| Film-coated | Thin polymer coat for taste/stability | Many antibiotics |
| Sugar-coated | Sugar layer for palatability | Some vitamins |
| Enteric-coated (EC) | Resists stomach acid; dissolves in intestine | Omeprazole, aspirin EC |
| Extended-release (ER/XR/SR/CR/XL) | Slow, sustained drug release | Morphine SR, metformin XR |
| Chewable | Crushed before swallowing; for paediatrics/elderly | Antacids, some antibiotics |
| Dispersible | Dissolves in water before taking | Co-amoxiclav dispersible |
| Capsule (hard gelatin) | Powder/granules in hard shell | Amoxicillin, omeprazole |
| Capsule (soft gelatin) | Liquid or semi-solid fill | Vitamin E, cyclosporine |
| Sachet | Powder in a single-dose packet dissolved in water | ORS, some analgesics |
Advantages: Self-administered, safe, economical, overdose can be managed (activated charcoal).
Disadvantages: First-pass metabolism reduces bioavailability; gastric pH destroys some drugs; unsuitable for unconscious patients.
- Bioavailability: 5% to <100% (oral) - Katzung's Basic and Clinical Pharmacology
B. Oral Liquid Forms
| Form | Description |
|---|
| Syrup | Concentrated sugar solution with dissolved drug |
| Elixir | Hydroalcoholic sweetened solution |
| Suspension | Drug particles dispersed in liquid (shake before use) |
| Solution | Drug fully dissolved in liquid |
C. Sublingual (SL) / Buccal
- Sublingual: Drug placed under the tongue
- Buccal: Drug placed between cheek and gum
- Both bypass the GI tract and avoid first-pass metabolism
- Rapid absorption directly into bloodstream
- Examples: Glyceryl trinitrate (GTN) for angina, buprenorphine
D. Rectal (PR)
- Drug delivered as suppositories, enemas, or gels
- ~50% bypasses the portal circulation, reducing first-pass metabolism
- Useful when: patient is vomiting, unconscious, or cannot take oral drugs
- Bioavailability: 30 to <100%
- Absorption can be erratic and incomplete
- Examples: Diazepam rectal solution, paracetamol suppositories
2. PARENTERAL (injected - bypasses GI tract)
Used when drugs are poorly absorbed from GI tract, destroyed by GI enzymes, or when rapid onset is needed.
| Route | Bioavailability | Speed | Notes |
|---|
| Intravenous (IV) | 100% (by definition) | Most rapid | No absorption step; immediate effect; no first-pass metabolism |
| Intramuscular (IM) | 75 to ≤100% | Rapid | Larger volumes possible; may be painful |
| Subcutaneous (SC) | 75 to ≤100% | Slower than IM | Smaller volumes; good for insulin; avoid irritant drugs |
| Intradermal (ID) | Low, local | Very slow | Used for diagnostic tests, allergy desensitization |
| Intrathecal | Direct CNS delivery | Rapid (CNS) | Bypasses blood-brain barrier; used for spinal anaesthesia |
| Epidural | Local/spinal | Variable | Pain management, obstetric analgesia |
Special parenteral forms:
- Depot injection - Slow-release drug in oil or microparticles (e.g., long-acting antipsychotics, contraceptive implants)
- Liposomal/lipid complex - Drug encapsulated in liposomes for targeted delivery (e.g., liposomal amphotericin B)
3. INHALATION
- Drug delivered as aerosol, gas, dry powder, or nebulised liquid
- Rapid onset (nearly as fast as IV) due to large lung surface area
- Ideal for respiratory conditions (asthma, COPD) - drug acts directly at site of action, minimising systemic side effects
- Bioavailability: 5 to <100%
- Examples: Salbutamol inhaler (MDI), budesonide (DPI), anaesthetic gases (isoflurane, nitrous oxide)
4. TOPICAL & TRANSDERMAL
| Form | Route | Use | Examples |
|---|
| Ointment | Skin (topical) | Local effect; greasy base | Hydrocortisone ointment |
| Cream | Skin (topical) | Local; water-washable | Antifungal cream |
| Lotion | Skin (topical) | Thin application to large areas | Calamine lotion |
| Gel | Skin/mucosa | Local or systemic | Diclofenac gel, testosterone gel |
| Drops | Eye/ear/nose | Local effect | Antibiotic eye drops, nasal decongestants |
| Transdermal patch | Skin (systemic) | Slow, sustained release; avoids first-pass | Fentanyl patch, nicotine patch, GTN patch |
"The rate of absorption [of transdermal drugs] can vary markedly, depending on the physical characteristics of the skin at the site of application, as well as the lipid solubility of the drug." - Lippincott
Transdermal bioavailability: 80 to ≤100%; very slow absorption; prolonged duration of action.
5. NASAL & OCULAR
| Form | Description | Examples |
|---|
| Nasal spray/drops | Absorbed across nasal mucosa; can be local or systemic | Intranasal corticosteroids, desmopressin |
| Eye drops/ointment | Local ocular effect | Timolol (glaucoma), chloramphenicol eye drops |
Summary Comparison Table
| Dosage Form | Route | Onset | Bioavailability | First-Pass? |
|---|
| Tablet (IR) | Oral | 30-60 min | Variable | Yes |
| Enteric-coated tablet | Oral | Delayed | Variable | Yes |
| Extended-release tablet | Oral | Slow/prolonged | Variable | Yes |
| Sublingual tablet | Sublingual | 2-5 min | High | No |
| IV injection | Intravenous | Immediate | 100% | No |
| IM injection | Intramuscular | 10-30 min | 75-100% | No |
| SC injection | Subcutaneous | 15-30 min | 75-100% | No |
| Transdermal patch | Skin | Hours | 80-100% | No |
| Inhaler | Lungs | Minutes | 5-100% | No |
| Suppository | Rectal | 15-30 min | 30-100% | Partial |
Sources: Lippincott Illustrated Reviews: Pharmacology; Katzung's Basic and Clinical Pharmacology (16th ed.); Park's Textbook of Preventive and Social Medicine; Goodman & Gilman's The Pharmacological Basis of Therapeutics